Christopher Juozaitis is the chief clinician at AdhereRx Inc., and co-owner/ pharmacy manager of Howe Sound Pharmacy. As a co-founder and clinical director of the company, he tailors workflow and clinical practice solutions to help pharmacy leaders sustainably improve patient outcomes and business results in any community pharmacy setting. With more than 34 years of experience in both the clinical and business sides of retail pharmacy, Chris respectfully collaborates with his fellow pharmacy owners to help them create and sustain their own atmospheres that compassionately and efficiently provide better care and education to both staff and patients. For nearly three decades, has co-owned one the country’s most clinically advanced community dispensaries.

Mr. Juozaitis still sees patients every day as he oversees a state-of-the-art home facility that incorporates a combination of innovative workflow, technology, environmental design and patient-centred communication that deliver superior outcomes in a cost-effective, patient-centred manner. Chris and his team are constantly improving pharmacy workflow designs, harnessing technology and refining staff training that allow pharmacists to practice at the fullest extent of their scope, concentrating on authentic patient engagement, drug therapy problems and proactive care plans.

Prior to joining Howe Sound Pharmacy and AdhereRx, Chris managed several community pharmacies. He has been active in sport, community and cultural outreach. Mr. Juozaitis holds a bachelor’s degree in pharmacy from the University of British Columbia, is a graduate of the CPhA ADAPT course, and focuses his practice in community applications of medication management and geriatrics.

Jim Danahy leads the day-to-day operations of AdhereRx Inc. and plays an active role in the operations of Howe Sound Pharmacy. A third generation retailer who grew up around his family’s pharmacy, Jim has led teams of pharmacists and technical experts to devise innovative medication adherence and profit improvement initiatives for independent and chain pharmacies across North and South America since 1994.

In early 2013, after nearly 20 years of research, Danahy released the first publicly available analysis demonstrating that medication adherence is a reliable marker of both patient outcomes and pharmacy profit. Mr. Danahy co-developed AdherenceTRACK the world’s first scorecard to measure continuous Rx adherence in retail pharmacies. In collaboration with Rubicon Pharmacies, Jim led a team that created Simpl™ the first retail brand of adherence services and packaging for community pharmacies. Other initiatives include: Rx-Guided Frontshop™ a process which optimizes OTC, natural health products (NHP), nutrition and home healthcare product assortments; License to Linger™ (L2L™), a lucrative front shop customer behavior model unique to freestanding drug stores. Jim and his team have extensive experience in retail inventory balancing, integration of POS with dispensary IT systems; remote dispensing technologies & automation; in-store traffic flow/display performance/ loss prevention analytics, M&A due diligence and post-merger integration.

Mr. Danahy has acted as an expert witness on retail legal matters and is frequently quoted on retail topics in US and Canadian business media. He is the founding Director of the Center of Excellence in Retail Leadership in the Schulich Executive Education Center at York University, advising senior executives at some of Canada’s largest retailers. Jim is past chair of Hope Air, Canada’s national charity which arranges air transportation to healthcare for people in financial need. He has held directorships on various industry association boards, and currently sits on advisory boards for the Retail Council of Canada and the international merchandise licensing body, LIMA. Jim holds a degree from Ryerson University.
He earned a degree in business at Wilfrid Laurier University, CPA and CA designations from the Institute of Chartered Accountants, CFP from the Financial Planning Standards Council and CIM Chartered Investment Manager designation from the Canadian Securities Institute.